Suppr超能文献

相似文献

1
The Impact of Diet on Clostridioides difficile Infection: A Review.
J Infect Dis. 2025 Jul 11;231(6):e1010-e1018. doi: 10.1093/infdis/jiaf233.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
4
Host origin of microbiota drives functional recovery and clearance in mice.
mBio. 2025 Jun 2:e0110825. doi: 10.1128/mbio.01108-25.
5
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
6
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Cochrane Database Syst Rev. 2013 May 31(5):CD006095. doi: 10.1002/14651858.CD006095.pub3.
7
Roles of Gut Microbiota and Associated Metabolites in Infection.
Pol J Microbiol. 2025 Jun 18;74(2):206-217. doi: 10.33073/pjm-2025-017. eCollection 2025 Jun 1.
8
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Cochrane Database Syst Rev. 2007 Jul 18(3):CD004610. doi: 10.1002/14651858.CD004610.pub3.
9
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004610. doi: 10.1002/14651858.CD004610.pub2.
10
The evolving landscape of live biotherapeutics in the treatment of Clostridioides difficile infection.
Indian J Gastroenterol. 2025 Apr;44(2):129-141. doi: 10.1007/s12664-024-01717-9. Epub 2025 Jan 16.

本文引用的文献

1
Fiber- and acetate-mediated modulation of MHC-II expression on intestinal epithelium protects from Clostridioides difficile infection.
Cell Host Microbe. 2025 Feb 12;33(2):235-251.e7. doi: 10.1016/j.chom.2024.12.017. Epub 2025 Jan 17.
2
The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization.
Am J Gastroenterol. 2025 Jan 1;120(1):98-105. doi: 10.14309/ajg.0000000000003085. Epub 2024 Sep 19.
3
and Gut Microbiota: From Colonization to Infection and Treatment.
Pathogens. 2024 Jul 31;13(8):646. doi: 10.3390/pathogens13080646.
5
Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in .
mBio. 2024 Mar 13;15(3):e0253523. doi: 10.1128/mbio.02535-23. Epub 2024 Jan 30.
6
Gut Microbiota-Gut Metabolites and Infection: Approaching Sustainable Solutions for Therapy.
Metabolites. 2024 Jan 22;14(1):74. doi: 10.3390/metabo14010074.
7
Clostridioides difficile infections; new treatments and future perspectives.
Curr Opin Gastroenterol. 2024 Jan 1;40(1):7-13. doi: 10.1097/MOG.0000000000000989. Epub 2023 Nov 9.
8
Butyrate enhances sporulation .
J Bacteriol. 2023 Sep 26;205(9):e0013823. doi: 10.1128/jb.00138-23. Epub 2023 Sep 1.
9
Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism.
Microbiol Spectr. 2023 Aug 17;11(4):e0447922. doi: 10.1128/spectrum.04479-22. Epub 2023 Jun 23.
10
Characterization of the gut microbiome of patients with infection, patients with non- diarrhea, and -colonized patients.
Front Cell Infect Microbiol. 2023 Apr 12;13:1130701. doi: 10.3389/fcimb.2023.1130701. eCollection 2023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验